|
Buprenorphine and Office-Based Treatment of Opioid Dependence Flyer
Download Flyer here
This training is presented by:
The American Psychiatric Association, Cicatelli Associates Inc., and the New York City Department of Health and Mental Hygiene
Location:
Cicatelli Associates Inc.
505 Eighth Avenue
20th floor
New York, NY 10018
Saturday, June 7, 2008
8:00 am-4:30 pm
Registration Begins at 7:00 am
|
|
You are invited to attend a day-long training on the use of buprenorphine in treating opioid addiction. Doctors who complete this training will qualify for a waiver to prescribe buprenorphine.
For Physicians in Publicly Funded Hospitals
Dates: Saturday, June 7, 2008
Time: 7 am - 8 am Breakfast and mandatory sign-in
8 am - 4:30 pm Program including lunch
4:30 Mandatory sign-out
Location: Cicatelli Associates Inc.
505 Eighth Avenue (@ 35th St.)
20th floor
NY, NY 10018
Directions: Subway - A,C,E,1,2,3 trains to 34th Street
Cost: Free
8.0 AMA PRA Category 1Credit(s)™ available
Accreditation: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through Cicatelli Associates Incorporated (CAI). CAI is accredited by the ACCME to provide continuing medical education for
physicians. CAI designates this educational activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This training is presented by:
The American Psychiatric Association, Cicatelli Associates Inc., and the New York City Department of Health and Mental Hygiene
This course will provide information to participants interested in learning about the treatment of opioid dependence and, in particular, physicians who wish to
provide office-based prescriptions of the medication buprenorphine. After successfully completing the course, physicians will have fulfilled the necessary training requirement and will qualify for a waiver to prescribe buprenorphine in an office-based setting. After participating in this course, participants should be able to describe:
· General aspects of opioid pharmacology
· Pharmacological characteristics of buprenorphine and its use for opioid dependence treatment
· Different levels of treatment services
· Psychiatric and medical co-morbidity
· Confidentiality
Finally, the course will utilize case-based, small-group discussions to illustrate and elaborate upon points brought up in didactic presentations.
|
